A focused biosimilar portfolio across diabetes, obesity and anticoagulation — manufactured end-to-end from one integrated facility at MEPZ-SEZ Chennai.
Out-licensing, in-licensing, distribution and contract manufacturing — we work across the value chain. Tell us which molecule and which market; we'll send the dossier package within 48 hours.